Evidence map›Paper›PMID 37928043›Full record

ArticleHeliyon2023

Nanocomposite based on Gd

Jaroslava Szűcsová, Adriana Zeleňáková, Eva Beňová, Ľuboš Nagy, Martin Orendáč, Veronika Huntošová, Mária Šoltésová, Jaroslav Kohout, Vít Herynek, Vladimír Zeleňák

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jaroslava SzűcsováInstitute of Physics, P. J. Šafárik University, Park Angelinum 9, 040 01 Kosice, Slovakia.
Adriana ZeleňákováInstitute of Physics, P. J. Šafárik University, Park Angelinum 9, 040 01 Kosice, Slovakia.
Eva BeňováInstitute of Chemistry, P. J. Šafárik University, Moyzesova 11, 040 01 Kosice, Slovakia.
Ľuboš NagyInstitute of Physics, P. J. Šafárik University, Park Angelinum 9, 040 01 Kosice, Slovakia.
Martin OrendáčInstitute of Physics, P. J. Šafárik University, Park Angelinum 9, 040 01 Kosice, Slovakia.
Veronika HuntošováCenter for Interdisciplinary Biosciences, P. J. Šafárik University, Jesenná 5, 040 01 Kosice, Slovakia.
Mária ŠoltésováDepartment of Low Temperature Physics, Faculty of Mathematics and Physics, Charles University, V Holešovičkách 2, 182 00 Prague, Czech Republic.
Jaroslav KohoutDepartment of Low Temperature Physics, Faculty of Mathematics and Physics, Charles University, V Holešovičkách 2, 182 00 Prague, Czech Republic.
Vít HerynekFirst Faculty of Medicine, Charles University, Center for Advanced Preclinical Imaging (CAPI), Salmovská 3, 120 00 Prague, Czech Republic.
Vladimír ZeleňákInstitute of Chemistry, P. J. Šafárik University, Moyzesova 11, 040 01 Kosice, Slovakia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have prepared silica matrix with hexagonal symmetry of pores (SBA-15) and loaded it with anticancer drug 5-Fluorouracil (5-FU) to promote it as a drug delivery system. Gd

Indexed as

5-Fluorouracildrug deliveryGd2O3 nanoparticlesmesoporous silicaMRI

Identifiers

PMID37928043
PMCPMC10623176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.